Hamman-Rich syndrome medical therapy

Jump to navigation Jump to search

Hamman-Rich syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hamman-Rich syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hamman-Rich syndrome medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hamman-Rich syndrome medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hamman-Rich syndrome medical therapy

CDC on Hamman-Rich syndrome medical therapy

Hamman-Rich syndrome medical therapy in the news

Blogs on Hamman-Rich syndrome medical therapy

Directions to Hospitals Treating Hamman-Rich syndrome

Risk calculators and risk factors for Hamman-Rich syndrome medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [2]

Overview

There is no effective treatment for acute interstitial pneumonitis, includes supportive therapy and glucocorticosteroids.

Supportive care

  • Patients with acute interstitial pneumonitis receive supportive care alongside the medical therapy:
    • Supplemental oxygen
    • Mechanical ventilation
    • Prevention of complications
      • Venous thromboembolism
      • Gastrointestinal bleeding
      • Hospital-acquired pneumonia
      • Sepsis
  • Pulmonary rehabilitation
  • Vaccination against possible causes of pulmonary inflammation as influenza and pneumococcal vaccines.

Medical Therapy

  • Corticosteroid therapy:
    • Once the diagnosis of acute interstitial pneumonitis is confirmed, high doses of glucocorticosteroids (eg, methylprednisolone) should be administered.
    • Monitor the patient for glucocorticosteroid-induced side effects (eg, hyperglycemia, increased susceptibility to infection, gastritis).
  • Immunosuppressive therapy

Template:WH Template:WS